A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Rondo Therapeutics
Hoffmann-La Roche
Immuneering Corporation
Carisma Therapeutics Inc
Nimbus Therapeutics
Merck Sharp & Dohme LLC
Mural Oncology, Inc
KitovPharma
Gary Onik MD